Top 10 Medical VC (Venture Capital) Funds in Taiwan in July 2025

Last updated: Jul 2025 A list of 10 VC (Venture Capital) funds that invest in Medical startups based in Taiwan. We rank investors based on the number of investments they made in Medical companies from Taiwan. We update this investor list every month.

Top 10 Medical VC (Venture Capital) Funds in Taiwan in July 2025

Investor	Medical Taiwan investments
National Development Fund of Taiwan Government	2
NCTU Angel Club	2
Translink Capital	2
Verge HealthTech Fund	2
Darwin Venture Management	2
TaiAn Technologies	1
Maxpro Ventures	1
Might Electronic	1
BE Healthcare Ventures	1
Taiwan Surface Mounting Technology	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Taiwan, United States, China

Portfolio highlights

FooSpace — FooSpace is an OMO smart retail solution provider enabling brands to start their offline and online business easily. With our technologies, much of the purchase, checkout, and payment steps associated with a retail transaction are completely automated. In the meantime, we focus on providing the right goods to the right people based on a variety ofdata collected by our innovative system.
PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.

NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.

Investment focus

Medical, Health Care, Biotechnology
Seed, Series A
Taiwan, United States

Portfolio highlights

MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.

Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.

Investment focus

Software, Information Technology, Artificial Intelligence
Series A, Series B, Series C
United States, China, South Korea

Portfolio highlights

Rescale — Rescale is a high performance computing cloud simulation platform that helps engineers and scientists build, compute, analyze, and scale simulations with high performance computing and automations.
Jobright — Discover your dream job with Jobright, your AI job search copilot. Find relevant opportunities tailored to your goals. Gain filtered matches, deep insights, and stay ahead with real-time company trends. Let Jobright find your perfect fit.
Makersite — AI, data and apps for procurement, product design and expert teams to make faster sustainable product and supply chain decisions, at scale.

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Investment focus

Health Care, Medical Device, Medical
Seed, Pre-Seed, Series A
Estonia, Singapore, United Kingdom

Portfolio highlights

Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
Lifeyear — Digital-first heart care. At scale.
CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.

Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.

Investment focus

Software, Manufacturing, Information Technology
Funding Round, Seed, Series A
Taiwan, United States, Japan

Portfolio highlights

KKday — KKday is an e-commerce travel platform that offers 10,000+ experiences around the world. It provides a wide breadth of experiences, including theme park tickets, cooking classes, multi-day tours, airport transfers, sim cards, and hidden sights off the beaten path. KKday was incorporated in 2014 and is headquartered in T'ai-pei, Taiwan.
Instalimb — Instalimb is the world's first 3D printing prosthesis business.
Findy — Findy is a Japanese company once surprised the world by sending out products such as cars and home appliances one after another

TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.

Investment focus

Biotechnology, Medical, Therapeutics
Series A, Series B
Taiwan, United States

Portfolio highlights

AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
APRINOIA Therapeutics — APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs,including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
Sapience Therapeutics — Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.

Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.

Investment focus

Medical, Oncology, Biotechnology
Series A
Taiwan

Portfolio highlights

AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.

Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.